ID
22615
Description
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4168g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus
Keywords
Versions (1)
- 6/8/17 6/8/17 -
Copyright Holder
Genentech, Inc.
Uploaded on
June 8, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
RetDQoL (DAY 0) CRFs Roche FVF4168G Macular Edema NCT00473330
RetDQoL (DAY 0) CRFs Roche FVF4168G Macular Edema NCT00473330
- StudyEvent: ODM
Similar models
RetDQoL (DAY 0) CRFs Roche FVF4168G Macular Edema NCT00473330
- StudyEvent: ODM
C2986440 (UMLS CUI [1,2])
No comments